UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 13, 2006
MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-12091 22-3436215
(Commission File Number) (I.R.S. Employer Identification No.)
Two Greenville Crossing, 4001 Kennett Pike, Suite 238 Greenville, Delaware 19807
(Address of principal executive offices) (Zip Code)
(713) 652-7200
(Registrant's telephone number, including area code)
1221 McKinney Street, Suite 700, Houston, Texas 77010
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On April 13, 2006, Millennium Chemicals Inc. ("Millennium"), announced that it has filed an application to voluntarily delist its 4% Senior Convertible Debentures due November 15, 2023 ("Convertible Debentures"), that are currently listed on the New York Stock Exchange and deregister these securities with the Securities and Exchange Commission. Millennium expects the delisting to be effective in May 2006. Millennium believes that the withdrawal of the listing and registration of the Convertible Debentures will have a negligible impact on investors. The April 13, 2006 press release regarding the matter is being filed with this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits.
99.1 Press Release
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MILLENNIUM CHEMICALS INC.
By:/s/ Kerry A. Galvin
Name: Kerry A. Galvin
Title: Senior Vice President, General Counsel & Secretary
Date: April 13, 2006
INDEX TO EXHIBITS
Exhibit
Number Description
99.1 Press Release